Literature DB >> 26342127

Bioinformatics tools for the analysis of NMR metabolomics studies focused on the identification of clinically relevant biomarkers.

Leonor Puchades-Carrasco, Martina Palomino-Schätzlein, Clara Pérez-Rambla, Antonio Pineda-Lucena.   

Abstract

Metabolomics, a systems biology approach focused on the global study of the metabolome, offers a tremendous potential in the analysis of clinical samples. Among other applications, metabolomics enables mapping of biochemical alterations involved in the pathogenesis of diseases, and offers the opportunity to noninvasively identify diagnostic, prognostic and predictive biomarkers that could translate into early therapeutic interventions. Particularly, metabolomics by Nuclear Magnetic Resonance (NMR) has the ability to simultaneously detect and structurally characterize an abundance of metabolic components, even when their identities are unknown. Analysis of the data generated using this experimental approach requires the application of statistical and bioinformatics tools for the correct interpretation of the results. This review focuses on the different steps involved in the metabolomics characterization of biofluids for clinical applications, ranging from the design of the study to the biological interpretation of the results. Particular emphasis is devoted to the specific procedures required for the processing and interpretation of NMR data with a focus on the identification of clinically relevant biomarkers.
© The Author 2015. Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Nuclear Magnetic Resonance; biomarker; metabolomics

Mesh:

Substances:

Year:  2015        PMID: 26342127     DOI: 10.1093/bib/bbv077

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  8 in total

Review 1.  Time is ripe: maturation of metabolomics in chronobiology.

Authors:  Seth D Rhoades; Arjun Sengupta; Aalim M Weljie
Journal:  Curr Opin Biotechnol       Date:  2016-10-01       Impact factor: 9.740

2.  Metabolic fingerprint of progression of chronic hepatitis B: changes in the metabolome and novel diagnostic possibilities.

Authors:  Hien Thi Thu Nguyen; Reinhard Wimmer; Vang Quy Le; Henrik Bygum Krarup
Journal:  Metabolomics       Date:  2021-01-25       Impact factor: 4.290

3.  NMR-Based Metabolomics in Cancer Research.

Authors:  Rui Hu; Tao Li; Yunhuang Yang; Yuan Tian; Limin Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN).

Authors:  Lillemor Berntson; Peter Agback; Johan Dicksved
Journal:  Clin Rheumatol       Date:  2016-03-29       Impact factor: 2.980

Review 5.  A Review of Recent Advancement in Integrating Omics Data with Literature Mining towards Biomedical Discoveries.

Authors:  Kalpana Raja; Matthew Patrick; Yilin Gao; Desmond Madu; Yuyang Yang; Lam C Tsoi
Journal:  Int J Genomics       Date:  2017-02-26       Impact factor: 2.326

6.  A Lactobacilli diet that confers MRSA resistance causes amino acid depletion and increased antioxidant levels in the C. elegans host.

Authors:  Katrine Vogt Møller; Hien Thi Thu Nguyen; Maria Grymer Metz Mørch; Marianne Overgaard Hesselager; Frans A A Mulder; Kurt Fuursted; Anders Olsen
Journal:  Front Microbiol       Date:  2022-07-28       Impact factor: 6.064

7.  Novelty detection for metabolic dynamics established on breast cancer tissue using 2D NMR TOCSY spectra.

Authors:  Lubaba Migdadi; Ahmad Telfah; Roland Hergenröder; Christian Wöhler
Journal:  Comput Struct Biotechnol J       Date:  2022-06-01       Impact factor: 6.155

8.  Deconvoluting interrelationships between concentrations and chemical shifts in urine provides a powerful analysis tool.

Authors:  Panteleimon G Takis; Hartmut Schäfer; Manfred Spraul; Claudio Luchinat
Journal:  Nat Commun       Date:  2017-11-21       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.